Prevalence and predictors of inappropriate anticoagulation in patients with a CHA 2 DS 2 -VASc score of 0 and atrial fibrillation

Antithrombotic Therapy in Atrial Fibrillation Management in Western Australia: Temporal Trends and Evidence-Treatment Gaps

“…A significant proportion of low risk patients were also receiving OAC therapy (40.5%). Over-use of OAC therapy in low risk patients has been described in other AF cohorts, although there may have been alternative indications for OAC therapy such as pulmonary thromboembolism and cardioversion in these patients [21][22][23]. In our study, alternative indications for OAC therapy were identified in only 8.3%.…”